WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'8101 Infant (under 12 months) mortality rate: 182
GDP / capita (US$): 4'4301 Child (under 5 years) mortality rate: 212

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 494  491  488  486  485  442  352  302 
Births 10  10  10  10  11  13  14  13 
Surviving infants 10  10  10  10  10  12  13  12 
Pop. less than 5 years 49  49  50  51  52  62  63  52 
Pop. less than 15 years 150  152  155  160  164  185  160  139 
Female 15-49 years 134  133  131  130  128  109  77  71 

Number of reported case

(Click for retrospective incidence data for Cabo Verde)
Diphtheria
Japanese encephalitis
Measles 1'279 
Mumps 40  198  42  13 
Pertussis 290 
Polio* 56  17 
Rubella 18  10  28  11'329  9'648 
Rubella (CRS) 16  46 
Tetanus (neonatal)
Tetanus (total) 40 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Cabo Verde)
Vaccine year result method % card seen                                                
BCG 2010  100  EPI   98.3  100  99  100  76  80  92  97 
DTP1 2010  100  EPI   98.3  98  99  100  73  80  93 
DTP3 2010  100  EPI   98.3  94  90  100  74  82  86  88 
HepB_BD          100  99  100  76  81 
HepB3 2010  98  EPI   98.3  94  90  98  73  82 
Hib3          94  90 
JapEnc         
MCV 2010  97  EPI   98.3  91  96  97  72  77  80  79 
MCV2          99 
PCV1         
PCV3         
Pol3 2010  100  EPI   98.3  94  90  100  74  82  86  87 
Rota1         
Rota_last         
Rubella1          99 
TT2plus 1997  38       64  45  90 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Cabo Verde)
BCG 99  99  99  99  99  96  97 
DTP1 99  99  99  99  99  94  96 
DTP3 90  90  99  99  99  90  88 
HepB3 90  90  98  98  98 
Hib3 90  90 
MCV 96  96  97  97  96  86  79 
PAB 92  92  92  78  78  60  75 
PCV3
Pol3 90  90  99  99  99  90  87 
Rota_last
YFV

Number of districts in the country 22  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 86
From 80 to 89% 9
From 50 to 79% 5
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HepB birth; Yes
MMR 15 months; Yes
Measles 9 months; Yes
OPV birth; 2, 4, 6, 18 months; Yes
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR No  No  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number     2006-2010  2006-2010  2006-2010  2006-2010  2006 -2010 
Nº of districts with microplans that include activities to raise immunization coverage number 22  22  17  17 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number 22  22  22  22  17  17  17 
Nº districts with DTP3 coverage >=80% number 21       
% of districts with DTP3 coverage >=80% From 0 to 100% 95        41  41  29 
Nº districts with measles (MCV1) coverage >=95% number          
% of districts with MCV1 coverage >=95% From 0 to 100% 41        24     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  No  No  No  No 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  No  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100%   100  100  84  84  90  90 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.